Medical — Other Operating Income
Becton, Dickinson and Company Medical — Other Operating Income remained flat by 0.0% to $4.25M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 950.0%, from -$500.00K to $4.25M. Over 2 years (FY 2023 to FY 2025), Medical — Other Operating Income shows an upward trend with a 68.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Frequent or large expenses may indicate operational instability or litigation risks, while consistent income can provide a minor boost to segment profitability.
Detailed definition
Captures miscellaneous operating items not categorized under COGS, SG&A, or R&D, such as gains or losses from asset disp...
Peer comparison
Standard 'Other Operating' line item found in segment-level financial disclosures.
bdx_segment_medical_other_operating_income_expense_netHistorical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | -$6.00M | -$2.00M | $17.00M |
| YoY Change | — | +66.7% | +950.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's medical — other operating income?
- Becton, Dickinson and Company (BDX) reported medical — other operating income of $4.25M in Q3 2025.
- How has Becton, Dickinson and Company's medical — other operating income changed year-over-year?
- Becton, Dickinson and Company's medical — other operating income increased by 950.0% year-over-year, from -$500.00K to $4.25M.
- What is the long-term trend for Becton, Dickinson and Company's medical — other operating income?
- Over 2 years (2023 to 2025), Becton, Dickinson and Company's medical — other operating income has grown at a 68.3% compound annual growth rate (CAGR), from -$6.00M to $17.00M.
- What does medical — other operating income mean?
- Net miscellaneous operating gains or losses for the medical segment.